Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Accounts Payable & Accrued Expense : ¥502 Mil (As of Mar. 2024)

View and export this data going back to 2012. Start your Free Trial

What is Beijing Bohui Innovation Biotechnology Group Co Accounts Payable & Accrued Expense?

Beijing Bohui Innovation Biotechnology Group Co's quarterly accounts payable & accrued expense increased from Sep. 2023 (¥583 Mil) to Dec. 2023 (¥615 Mil) but then declined from Dec. 2023 (¥615 Mil) to Mar. 2024 (¥502 Mil).

Beijing Bohui Innovation Biotechnology Group Co's annual accounts payable & accrued expense declined from Dec. 2021 (¥2,052 Mil) to Dec. 2022 (¥626 Mil) and declined from Dec. 2022 (¥626 Mil) to Dec. 2023 (¥615 Mil).

Beijing Bohui Innovation Biotechnology Group Co Accounts Payable & Accrued Expense Historical Data

The historical data trend for Beijing Bohui Innovation Biotechnology Group Co's Accounts Payable & Accrued Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Beijing Bohui Innovation Biotechnology Group Co Accounts Payable & Accrued Expense Chart

Beijing Bohui Innovation Biotechnology Group Co Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Accounts Payable & Accrued Expense

Get a 7-Day Free Trial

910.56

1,510.12

2,051.85

625.89

615.25

Beijing Bohui Innovation Biotechnology Group Co Quarterly Data
	Jun19	Sep19	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24
Accounts Payable & Accrued Expense	Get a 7-Day Free Trial															557.94	559.67	583.25	615.25	501.72

Beijing Bohui Innovation Biotechnology Group Co Accounts Payable & Accrued Expense Calculation

Accounts payable & accrued expense usually includes accounts payable, accrued compensation and related benefits, etc.

Accounts payable is money owed by a business to its suppliers shown as a liability on a company's balance sheet. It is distinct from notes payable liabilities, which are debts created by formal legal instrument documents.

It is part of the current portion of the liabilities (due within one year or within the normal operating cycle if longer) reflected on the balace sheet of the company. A higher Accounts Payable means lower Working Capital needed to operate the business.

Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Beijing Bohui Innovation Biotechnology Group Co Ltd (SZSE:300318) » Definitions » Accounts Payable & Accrued Expense

Comparable Companies

Traded in Other Exchanges

N/A

Address

Block G Jingxinyuan, NO.25 Jia Beiwucun Road, Haidian, Beijing, CHN, 100097

Website

http://www.bohui-tech.com

Beijing Bohui Innovation Biotechnology Co Ltd operates in the medical device industry. The company is focusing on the research and development, production, sales and after-sales services of in vitro diagnostic products. The main products of the company include human element detection system, vitamin D test kits and infectious pathogen detection system. The company serves over 3,000 healthcare institutions in 31 provinces and autonomous regions in China.

Beijing Bohui Innovation Biotechnology Group Co (SZSE:300318) Headlines

No Headlines